Similar articles

• Effect of Roflumilast and Inhaled Corticosteroid/Long-Acting β2-Agonist on Chronic Obstructive Pulmonary Disease Exacerbations (RE(2)SPOND). A Randomized Clinical Trial.

  Martinez FJ, Rabe KF, Sethi S, Pizzichini E, McIvor A, Anzueto A, Alagappan VK, Siddiqui S, Rekeda L, Miller CJ, Zetterstrand S, Reisner C, Rennard SI. Martinez FJ, et al. Am J Respir Crit Care Med. 2016 Sep 1;194(5):559-67. doi: 10.1164/rccm.201607-1349OC. Am J Respir Crit Care Med. 2016. PMID: 27585384 Clinical Trial.
• Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.

  Spencer S, Evans DJ, Karner C, Cates CJ. Spencer S, et al. Cochrane Database Syst Rev. 2011 Oct 5;(10):CD007033. doi: 10.1002/14651858.CD007033.pub2. Cochrane Database Syst Rev. 2011. Update in: Cochrane Database Syst Rev. 2011 Dec 07;(12):CD007033. doi: 10.1002/14651858.CD007033.pub3. PMID: 21975759 Updated. Review.
• Intensified Therapy with Inhaled Corticosteroids and Long-Acting β₂-Agonists at the Onset of Upper Respiratory Tract Infection to Prevent Chronic Obstructive Pulmonary Disease Exacerbations. A Multicenter, Randomized, Double-Blind, Placebo-controlled Trial.

  Stolz D, Hirsch HH, Schilter D, Louis R, Rakic J, Boeck L, Papakonstantinou E, Schindler C, Grize L, Tamm M. Stolz D, et al. Am J Respir Crit Care Med. 2018 May 1;197(9):1136-1146. doi: 10.1164/rccm.201709-1807OC. Am J Respir Crit Care Med. 2018. PMID: 29266965 Clinical Trial.
• Combined corticosteroid and long-acting beta-agonist in one inhaler versus long-acting beta-agonists for chronic obstructive pulmonary disease.

  Nannini LJ, Cates CJ, Lasserson TJ, Poole P. Nannini LJ, et al. Cochrane Database Syst Rev. 2007 Oct 17;(4):CD006829. doi: 10.1002/14651858.CD006829. Cochrane Database Syst Rev. 2007. Update in: Cochrane Database Syst Rev. 2012 Sep 12;(9):CD006829. doi: 10.1002/14651858.CD006829.pub2. PMID: 17943918 Updated. Review.
• Combined corticosteroid and long acting beta-agonist in one inhaler for chronic obstructive pulmonary disease.

  Nannini L, Cates CJ, Lasserson TJ, Poole P. Nannini L, et al. Cochrane Database Syst Rev. 2004;(3):CD003794. doi: 10.1002/14651858.CD003794.pub2. Cochrane Database Syst Rev. 2004. Update in: Cochrane Database Syst Rev. 2007 Oct 17;(4):CD003794. doi: 10.1002/14651858.CD003794.pub3. PMID: 15266502 Updated. Review.